Rushi Vekariya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rushi Vekariya has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Kimia Zadeh
Department of Infectious Diseases & Immunology, University of Florida, Gainesville, FL 32608, USA
1 shared publication - Mojgan Zadeh
Department of Infectious Diseases & Immunology, University of Florida, Gainesville, FL 32608, USA
1 shared publication - William Roth
Department of Neurology, University of Florida, Gainesville, FL 32608, USA
1 shared publication - Yong Ge
Department of Infectious Diseases & Immunology, University of Florida, Gainesville, FL 32608, USA
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 15 March 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (6) , 2973
Tryptophan Metabolism and Gut-Brain Homeostasis
Tryptophan is an essential amino acid critical for protein synthesis in humans that has emerged as a key player in the microbiota-gut-brain axis. It is the only precursor for the neurotransmitter serotonin, which is vital for the processing of emotional regulation, hunger, sleep, and pain, as well as colonic motility and secretory activity in the gut. Tryptophan catabolites from the kynurenine degradation pathway also modulate neural activity and are active in the systemic inflammatory cascade. Additionally, tryptophan and its metabolites support the development of the central and enteric nervous systems. Accordingly, dysregulation of tryptophan metabolites plays a central role in the pathogenesis of many neurologic and psychiatric disorders. Gut microbes influence tryptophan metabolism directly and indirectly, with corresponding changes in behavior and cognition. The gut microbiome has thus garnered much attention as a therapeutic target for both neurologic and psychiatric disorders where tryptophan and its metabolites play a prominent role. In this review, we will touch upon some of these features and their involvement in health and disease.
- 15 March 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (6) , 2973
Top Cited PapersOpen AccessTryptophan Metabolism and Gut-Brain Homeostasis
Tryptophan is an essential amino acid critical for protein synthesis in humans that has emerged as a key player in the microbiota-gut-brain axis. It is the only precursor for the neurotransmitter serotonin, which is vital for the processing of emotional regulation, hunger, sleep, and pain, as well as colonic motility and secretory activity in the gut. Tryptophan catabolites from the kynurenine degradation pathway also modulate neural activity and are active in the systemic inflammatory cascade. Additionally, tryptophan and its metabolites support the development of the central and enteric nervous systems. Accordingly, dysregulation of tryptophan metabolites plays a central role in the pathogenesis of many neurologic and psychiatric disorders. Gut microbes influence tryptophan metabolism directly and indirectly, with corresponding changes in behavior and cognition. The gut microbiome has thus garnered much attention as a therapeutic target for both neurologic and psychiatric disorders where tryptophan and its metabolites play a prominent role. In this review, we will touch upon some of these features and their involvement in health and disease.